- Machine learning cybersecurity startup Darktrace Ltd. said today it has raised $50 million in new late-stage funding on a valuation of $1.65 billion to further international expansion and development.
- The Series E round was led by Vitruvian Partners and included existing investors KKR and 1011 Ventures.
- Founded in 2013, Darktrace pitches itself as the leader in “Enterprise Immune System Technology” with a cybersecurity product that tackles advanced cyberthreats using a machine learning platform developed at the United Kingdom’s University of Cambridge.
- Differentiating itself from others in the market, Darktrace claims its platform is based on the “biological principles of the human immune system.” It also says the platform can learn “self,” which is said to constitute “the normal pattern of life for the organization, its users and devices – and detecting subtle deviations from this normal behavior, which suggest a compromise, breach or cyber-attack.”
Duncan Riley / SiliconANGLE - 9 months ago